Narcolepsy is a chronic neurological disorder, which is characterized
by brain’s inability to control the sleep-wake cycle of an
individual. This disorder is not caused due to any mental illness,
but is mainly caused due to genetic abnormalities occurring from
environmental factors or biologic factors.
Report Overview @
https://www.transparencymarketresearch.com/narcolepsy-market.html
Narcoleptic individuals exhibita typical characteristic symptom, i.e.
excessive daytime sleepiness (EDS), where individuals experience
disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy
disorder is often confused with insomnia. Other major symptoms of
this disorder include, cataplexy, sleep paralysis, hypnagogic
hallucinations, automatic behavior and night weakness.
Some of the major factors driving the growth of this market include
increasing prevalence of various sleep disorders including
narcolepsy, rising awareness about the disorder and increasing demand
for advanced therapeutics and diagnostics.Narcoleptic disorder is
equally prevalent to Parkinson’s disease or multiple sclerosis and
is more prevalent than cystic fibrosis. There are more than 3 million
people suffering from this disorder worldwide.
Rising awareness about the disorder, and the resultant increase in
demand for new and innovative drugs and other treatment optionswill
lead to the growth of this market in future.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2362
Geographically, North America dominates the global narcolepsy market
followed by Europe. Major factors responsible for their dominance are
high prevalence rate of narcolepsy in these regions. U.S. alone
accounts for more than 200,000 narcoleptic individuals and is also
characterized by high awareness levels among the general population.
Asia-Pacific region exhibited fastest growth in this market due to
increasing awareness levels about the disease and its treatment
options and increasing spending power of the population.
Some of the key players operating in this market are Addrenex
Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET,
Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc.,
Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva
Pharmaceutical Industries Ltd.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=2362<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment